SOAT1 and early-onset autosomal dominant Alzheimer disease: Taking into account the proposed ischemic theory of Alzheimer’s disease, where the possibility of influencing the JAK/STAT signaling pathway has been shown in the brain after experimental ischemia, this target is likely to be used in the prevention or treatment of Alzheimer’s disease [12,13,14,15,16].